Diligence memo · auto-generated · as of July 3, 2026
Key Biologics Holdings, LLC
Key Biologics Holdings, LLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Key Biologics Holdings, LLC operates in Biotech / Pharma, based in MEMPHIS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Key Biologics Holdings, LLC has raised $11M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.6M on 2018-06-05.
Most recent recorded round closed around 2018-08-03.
Valuation (modeled)modeled
Provath models Key Biologics Holdings, LLC at approximately $168M (range $5.6M–$911M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.77× the median modeled value of Series A Biotech / Pharma companies in 2016–2018 (5 peers) — value vs value, same stage and era. Within the normal band (77% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 2 months.
Last raise 7.9 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 63% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 78% of those peers.
Closest niche peers: Oncoheroes Biosciences Inc., Pharmaca Integrative Pharmacy Inc, PharmacoPhotonics, Inc., Swift Biosciences, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.